EveroliMus-d4
EveroliMus-d4 Basic information
- Product Name:
- EveroliMus-d4
- Synonyms:
-
- EveroliMus-d4 (~90%)
- Everolimus Impurity 24(Everolimus-d4)
- EVEROLIMUS (2-HYDROXYETHYL-D4, 98%)
- Everolimus-d4
- Everolimus D4Q: What is Everolimus D4 Q: What is the CAS Number of Everolimus D4 Q: What is the storage condition of Everolimus D4 Q: What are the applications of Everolimus D4
- Everolimus-d4 (Everolimus Impurity)
- CAS:
- 1338452-54-2
- MF:
- C53H79D4NO14
- MW:
- 962.249067112
- Mol File:
- 1338452-54-2.mol
EveroliMus-d4 Chemical Properties
- storage temp.
- Store at 4°C
- solubility
- Chloroform: Soluble,Methanol: Soluble
- form
- A solid
- color
- White to off-white
- Stability:
- Hygroscopic
EveroliMus-d4 Usage And Synthesis
Description
Everolimus-d4 is intended for use as an internal standard for the quantification of everolimus by GC- or LC-MS. Everolimus is a hydroxyethyl ether form of rapamycin that inhibits mTOR signaling through both mTORC1 and mTORC2 when added to cells at 20 nM. It is orally available and shows improved pharmacokinetics and pharmacodynamics over rapamycin. Through its inhibition of mTOR, everolimus inhibits cell proliferation, metabolism, and angiogenesis in certain types of cancer. It also acts as an immunosuppressive agent in the context of organ transplantation.
Uses
Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation.
General Description
A stable-labeled internal standard for the immunosuppressant Everolimus, marketed as Zortress? and Certican for use in organ transplantation and Afinitor? for treatment of kidney and pancreatic cancers. Clinical laboratories quantitate everolimus levels in patient whole blood samples using LC-MS/MS. While many everolimus LC-MS/MS methods use 32-desmethoxyrapamycin or ascomycin as an internal standard, higher levels of variability / lower levels of reproducibility may occur in the analysis along with the potential for interferences. Use of a stable-labeled analog of everolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.
EveroliMus-d4Supplier
- Tel
- 021-50135380
- shchemsky@sina.com
- Tel
- 400-400-6206333 18521732826
- market@aladdin-e.com
- Tel
- 020-81960175
- min.he@cato-chem.com
- Tel
- 0575-18780151478 18582380095
- sales@artisbio.com
- Tel
- 025-84622273 17361806303
- 3004208264@qq.com
EveroliMus-d4(1338452-54-2)Related Product Information
- Everolimus O-Ethyl Impurity
- EveroliMus iMpurity
- Everolimus Related Compound 3
- Everolimus
- Everolimus Ring-Opening Impurity
- 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone
- Everolimus Impurity 1
- USDOYNAPNXMXOE-SPSCNLKESA-N
- 23,27-Epoxy(7E,15E,17E,19E)-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-10,21-dimethoxy-6,8,12,14,20,26-hexam...
- Rapamycin, 32-O-demethyl-
- Seco Rapamycin
- Everolimus Hydrolized Impurity
- 28-epirapamycin
- BIS(T-BUTYLDIMETHYLSILOXY)ETHANE
- Methanesulfonic acid, trifluoro-, 2-hydroxyethyl ester
- Ethyleneglycol bistriflate
- Everolimus Related Compound 2
- 2-(tert-butyldiMethylsilyl )oxyl alcohol trifluorin Methanesulfonate